The Systemic-Onset Variant of Juvenile Idiopathic Arthritis Needs to Be Recorded as an Autoinflammatory Syndrome: Comment on the Review by Nigrovic-Reference-Cited by-同舟云学术

The Systemic-Onset Variant of Juvenile Idiopathic Arthritis Needs to Be Recorded as an Autoinflammatory Syndrome: Comment on the Review by Nigrovic

Published:2014-08-26 Issue:9 Volume:66 Page:2645-2645
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Rigante Donato¹,Cantarini Luca²

Affiliation:

1. Università Cattolica Sacro Cuore; Rome Italy

2. Università di Siena; Siena Italy

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.38698/fullpdf

Reference5 articles.

1. Is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?;Nigrovic;Arthritis Rheumatol,2014

2. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001;Petty;J Rheumatol,2004

3. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions;Mellins;Nat Rev Rheumatol,2011

4. Is Still's disease an autoinflammatory syndrome?;Rossi-Semerano;Int J Inflam,2012

5. Role of interleukin-1(IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade;Pascual;J Exp Med,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Methotrexate's role as a potential inducer of macrophage activation syndrome in Still's disease;International Journal of Rheumatic Diseases;2024-05

2. Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors;Arthritis & Rheumatology;2019-10

3. Macrophage Activation Syndrome in Rheumatic Diseases;Textbook of Autoinflammation;2019

4. Macrophage Activation Syndrome in Rheumatic Diseases (MAS-HLH);Histiocytic Disorders;2017-06-16

5. Investigational drugs for treatment of juvenile idiopathic arthritis;Expert Opinion on Investigational Drugs;2017-03-12